NCT05352048

Brief Summary

The purpose of this study is to determine how well mechanomyography (MMG) and electromyography (EMG) prevent cortical bone breaches, or the pinching of a nerve from screw placement, in patients having lower back surgery requiring hardware. Both MMG and EMG are devices approved by the FDA to detect the location of nerves during surgery so they can be avoided. The results from both tests will be compared to one another to determine if one is better at accurately locating nerves than the other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 28, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 2, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

August 19, 2025

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

April 22, 2022

Results QC Date

June 27, 2025

Last Update Submit

August 1, 2025

Conditions

Keywords

Lower back surgeryLumbar fusion

Outcome Measures

Primary Outcomes (1)

  • Success of Pedicle Screw Trajectories

    Patients with successful pedicle screw trajectories determined by the percentage of patients with A/B or C/D/E breaches. * Grade A - No cortical breach (0 mm) * Grade B - Pedicle cortical breach \< 2 mm * Grade C - Pedicle cortical breach = 2 to \< 4 mm * Grade D - Pedicle cortical breach = 4 to \< 6 mm * Grade E - Pedicle cortical breach = 6 mm

    1 hour

Secondary Outcomes (6)

  • Change From Baseline in the Numeric Rating Scale (NRS) Questionnaire for Pain.

    3 months after surgery

  • Change From Baseline in the Oswestry Disability Index Version 2.1A

    3 months after surgery

  • Change From Baseline in the PROMIS Global-10

    3 months after surgery

  • Change in the Short-From (SF-36) Health Survey

    6 weeks and 3 months after surgery

  • Hospital Readmission at 30 Days

    30 days

  • +1 more secondary outcomes

Study Arms (1)

Intraoperative MMG vs EMG for cortical breach detection

EXPERIMENTAL

Participants in this arm will be assessed with both MMG and EMG during their lower spine fusion surgery.

Device: Triggered ElectromyographyDevice: Mechanomyography

Interventions

Triggered electromyography will be used during surgery to detect nerve impingement by pedicle screws used for spinal fusion. Threshold stimulation data from the device will be recorded.

Intraoperative MMG vs EMG for cortical breach detection

SENTIO MMG ball tip probe will be used during surgery to detect nerve impingement by pedicle screws used for spinal fusion. Threshold stimulation data from the device will be recorded, and the accuracy compared to the data from the triggered electromyography.

Also known as: SENTIO MMG
Intraoperative MMG vs EMG for cortical breach detection

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • scheduled to undergo a one-, two-, or three-level posterolateral spinal fusion surgery using Depuy Synthes Expedium pedicle screw instrumentation.
  • over the age of 18 years old
  • unresponsive to conservative care for a minimum of 6 months
  • psychosocially, mentally, and physically able to fully consent and comply with this protocol

You may not qualify if:

  • preexisting medical condition or comorbidity that makes them a poor candidate
  • open wound local to the operative area, or rapid joint disease, bone absorption, or osteoporosis
  • requires medications that may interfere with bone or soft tissue healing
  • active local or systemic infection
  • metal sensitivity/foreign body sensitivity
  • implanted pacemaker
  • morbidly obese, defined as a body mass index (BMI) greater than 45
  • osteoporosis
  • involved in or planning to engage in litigation or receiving Workers Compensation related to neck or back pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40536, United States

Location

Results Point of Contact

Title
Dr. Francis Farhadi
Organization
University of Kentucky

Study Officials

  • H. Francis Farhadi, MD, PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 22, 2022

First Posted

April 28, 2022

Study Start

August 2, 2022

Primary Completion

July 9, 2024

Study Completion

November 6, 2024

Last Updated

August 19, 2025

Results First Posted

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations